Reply: The PARAGON-HF Trial: Toward Extension to Patients With HF Middle Range Ejection Fraction

JACC Heart Fail. 2020 Aug;8(8):698-699. doi: 10.1016/j.jchf.2020.06.005.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Aminobutyrates
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure* / therapy
  • Humans
  • Natriuretic Peptide, Brain*
  • Stroke Volume
  • Tetrazoles
  • Valsartan

Substances

  • Aminobutyrates
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Natriuretic Peptide, Brain
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination